Go to
JCI Insight
Citations to this article
Mi-Hwa Kim, … , In-Youb Chang, Ho Jin You
Published July 1, 2013
Citation Information: J Clin Invest. 2013;123(8):3211-3230. https://doi.org/10.1172/JCI65521.
Citation Information: J Clin Invest. 2013;123(8):3211-3230. https://doi.org/10.1172/JCI65521.
Abstract
Aberrant expression of apurinic-apyrimidinic endonuclease–1 (APEX1) has been reported in numerous human solid tumors and is positively correlated with cancer progression; however, the role of APEX1 in tumor progression is poorly defined. Here, we show that APEX1 contributes to aggressive colon cancer behavior and functions as an upstream activator in the Jagged1/Notch signaling pathway. APEX1 overexpression or knockdown in human colon cancer cell lines induced profound changes in malignant properties such as cell proliferation, anchorage-independent growth, migration, invasion, and angiogenesis in vitro and in tumor formation and metastasis in mouse xenograft models. These oncogenic effects of APEX1 were mediated by the upregulation of Jagged1, a major Notch ligand. Furthermore, APEX1 expression was associated with Jagged1 in various colon cancer cell lines and in tissues from colon cancer patients. This finding identifies APEX1 as a positive regulator of Jagged1/Notch activity and suggests that it is a potential therapeutic target in colon cancers that exhibit high levels of Jagged1/Notch signaling.
Authors
Mi-Hwa Kim, Hong-Beum Kim, Sang Pil Yoon, Sung-Chul Lim, Man Jin Cha, Young Jin Jeon, Sang Gon Park, In-Youb Chang, Ho Jin You
Total citations by year
Citation information
Citations to this article (31)
| Title and authors | Publication | Year |
|---|---|---|
|
Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology.
Kumar S, Kumar BH, Nayak R, Pandey S, Kumar N, Pai KSR |
Molecular diversity | 2025 |
|
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.
Tang S, Wang Y, Luo R, Fang R, Liu Y, Xiang H, Ran P, Tong Y, Sun M, Tan S, Huang W, Huang J, Lv J, Xu N, Yao Z, Zhang Q, Xu Z, Yue X, Yu Z, Akesu S, Ding Y, Xu C, Lu W, Zhou Y, Hou Y, Ding C |
Nature Communications | 2024 |
|
Schlafen 12 slows TNBC tumor growth, induces luminal markers and predicts favorable survival
Sandeep K Singhal, Sarmad Al-Marsoummi, Emilie Vomhof-DeKrey, Bo Lauckner, Trysten Beyer, Marc Basson |
Cancers | 2023 |
|
NEDD4 attenuates oxidized low‑density lipoprotein‑induced inflammation and dysfunction in vascular endothelial cells via regulating APEX1 expression
Xu H, Tan L, Qu Q, Zhang W |
Experimental and therapeutic medicine | 2023 |
|
APEX1 predicts poor prognosis of gallbladder cancer and affects biological properties of CD133+ GBC-SD cells via upregulating Jagged1
Wu Z, Liu Z, Sun Y, Yuan Y, Zou Q, Wen Y, Luo J, Liu R |
Journal of Cancer | 2023 |
|
Exploring homologous recombination repair and base excision repair pathway genes for possible diagnostic markers in hematologic malignancies.
Abbasi SF, Mahjabeen I, Parveen N, Qamar I, Haq MFU, Shafique R, Saeed N, Ashraf NS, Kayani MA |
Molecular genetics and genomics : MGG | 2023 |
|
In-depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer.
Garranzo-Asensio M, Rodríguez-Cobos J, San Millán C, Poves C, Fernández-Aceñero MJ, Pastor-Morate D, Viñal D, Montero-Calle A, Solís-Fernández G, Ceron MÁ, Gámez-Chiachio M, Rodríguez N, Guzmán-Aránguez A, Barderas R, Domínguez G |
Molecular Oncology | 2022 |
|
5FU/Oxaliplatin-Induced Jagged1 Cleavage Counteracts Apoptosis Induction in Colorectal Cancer: A Novel Mechanism of Intrinsic Drug Resistance.
Pelullo M, Zema S, De Carolis M, Cialfi S, Giuli MV, Palermo R, Capalbo C, Giannini G, Screpanti I, Checquolo S, Bellavia D |
Frontiers in Oncology | 2022 |
|
Genomic variants within chromosome 14q32.32 regulate bone mass through MARK3 signaling in osteoblasts
Qian Zhang, Larry D. Mesner, Gina M. Calabrese, Naomi Dirckx, Zhu Li, Angela Verardo, Qian Yang, Robert J. Tower, Marie-Claude Faugere, Charles R. Farber, Thomas L. Clemens |
Journal of Clinical Investigation | 2021 |
|
Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha
BD Yun, SW Son, SY Choi, HJ Kuh, TJ Oh, JK Park |
International journal of molecular sciences | 2021 |
|
LINC00470 accelerates the proliferation and metastasis of melanoma through promoting APEX1 expression
T Huang, YJ Wang, MT Huang, Y Guo, LC Yang, XJ Liu, WY Tan, JH Long |
Cell Death and Disease | 2021 |
|
Expression of Parkin, APC, APE1, and Bcl-xL in Colorectal Polyps
RK Baldin, CA Ribas, L de Noronha, CC da Silva-Camargo, VS Sotomaior, AP Sebastião, AP de Castilho, MR Netto |
Journal of Histochemistry & Cytochemistry | 2021 |
|
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression
J He, RP McLaughlin, L van der Beek, S Canisius, L Wessels, M Smid, JW Martens, JA Foekens, Y Zhang, B van de Water |
Oncogene | 2020 |
|
APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma
L Cao, H Cheng, Q Jiang, H Li, Z Wu |
Aging | 2020 |
|
APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
YD Choi, JY Jung, M Baek, S Khan, PI Song, S Ryu, JY Koo, SC Chauhan, A Tsin, C Choi, WJ Kim, M Kim |
International journal of molecular sciences | 2020 |
|
Novel tumour suppressor roles for GZMA and RASGRP1 in Theileria annulata ‐transformed macrophages and human B lymphoma cells
Z Rchiad, M Haidar, HR Ansari, S Tajeri, S Mfarrej, FB Rached, A Kaushik, G Langsley, A Pain |
Cellular Microbiology | 2020 |
|
AP endonuclease 1 (Apex1) influences brain development linking oxidative stress and DNA repair
DS Pei, PP Jia, JJ Luo, W Liu, PR Strauss |
Cell Death and Disease | 2019 |
|
miR‑296‑3p targets APEX1 to suppress cell migration and invasion of non‑small‑cell lung cancer
L Wang, R Chen, Y Zhang |
Oncology Letters | 2019 |
|
Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells
V Vaish, J Kim, M Shim |
Oncotarget | 2017 |
|
Selective regulation of Notch ligands during angiogenesis is mediated by vimentin
D Antfolk, M Sjöqvist, F Cheng, K Isoniemi, CL Duran, A Rivero-Muller, C Antila, R Niemi, S Landor, CV Bouten, KJ Bayless, JE Eriksson, CM Sahlgren |
Proceedings of the National Academy of Sciences | 2017 |
|
Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancer
HB Kim, WJ Cho, NG Choi, SS Kim, JH Park, HJ Lee, SG Park |
Annals of Surgical Treatment and Research | 2017 |
|
Apelin13/APJ promotes proliferation of colon carcinoma by activating Notch3 signaling pathway
T Chen, N Liu, GM Xu, TJ Liu, Y Liu, Y Zhou, SB Huo, K Zhang |
Oncotarget | 2017 |
|
BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
G Andrieu, AH Tran, KJ Strissel, GV Denis |
Cancer research | 2016 |
|
Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile
J Gao, M Zhang, H Li, D Zou |
OncoTargets and therapy | 2016 |
|
High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancer
M Sugiyama, E Oki, Y Nakaji, S Tsutsumi, N Ono, R Nakanishi, M Sugiyama, Y Nakashima, H Sonoda, K Ohgaki, N Yamashita, H Saeki, S Okano, H Kitao, M Morita, Y Oda, Y Maehara |
Cancer Science | 2016 |
|
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer: NOTCH1 Gene Copy Number Gain
JJ Arcaroli, WM Tai, R McWilliams, S Bagby, PJ Blatchford, M Varella-Garcia, A Purkey, KS Quackenbush, EK Song, TM Pitts, D Gao, C Lieu, M McManus, AC Tan, X Zheng, Q Zhang, M Ozeck, P Olson, ZQ Jiang, S Kopetz, A Jimeno, S Keysar, G Eckhardt, WA Messersmith |
International Journal of Cancer | 2015 |
|
Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis
VD Maso, MG Mediavilla, C Vascotto, F Lupo, U Baccarani, C Avellini, G Tell, C Tiribelli, LS Crocè, MA Avila |
PloS one | 2015 |
|
Association of APE1 Gene Asp148Glu Variant with Digestive Cancer: A Meta-Analysis
G Tian |
Medical science monitor : international medical journal of experimental and clinical research | 2015 |
|
The Notch ligand Jagged1 as a target for anti-tumor therapy
D Li |
Frontiers in Oncology | 2014 |
|
Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer
Y Dai, G Wilson, B Huang, M Peng, G Teng, D Zhang, R Zhang, MP Ebert, J Chen, BC Wong, KW Chan, J George, L Qiao |
Cell Death and Disease | 2014 |
|
Conditioned Medium from Hypoxic Bone Marrow-Derived Mesenchymal Stem Cells Enhances Wound Healing in Mice
L Chen, Y Xu, J Zhao, Z Zhang, R Yang, J Xie, X Liu, S Qi, M Pesce |
PloS one | 2014 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)